Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia

Previous studies have shown that metformin or statins may decrease hepatocellular carcinoma (HCC) in diabetic patients. Accordingly, this article evaluates whether combination therapy may further reduce HCC. Newly diagnosed type 2 diabetes mellitus (DM) patients, excluding those with history of mali...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsin-Hung, Lin, Ming-Chia, Muo, Chih-Hsin, Yeh, Su-Yin, Sung, Fung-Chang, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616544/
https://www.ncbi.nlm.nih.gov/pubmed/26091447
http://dx.doi.org/10.1097/MD.0000000000001013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616544/
https://www.ncbi.nlm.nih.gov/pubmed/26091447
http://dx.doi.org/10.1097/MD.0000000000001013

Ejemplares similares